Gilead Sciences, the U.S. leader in the field of HIV / AIDS drugs, with global sales of $ 5.4 billion in 2009, held a number of innovative measures to make its anti-virus products available in more than 100 low-and middle- income. Reaching nearly 680,000 patients in the middle of 2009, top managers are expected to reach 2 million patients in 2012.
To enhance their effectiveness, color cases should be printed in color. "Hide
by V. Kasturi Rangan, Katharine Lee Source: Harvard Business School 28 pages. Publication Date: October 08, 2009. Prod. #: 510029-PDF-ENG
Related Case Solutions & Analyses:
ADR Choices Video (Alternative Dispute Resolution Vignettes) Video
Note on the Law of Sexual Harassment
INSEAD
Fortis Healthcare (B)
Thats a Wrap: The Dynamics of the Video Rental Industry
NeuroTherapy Ventures: Catalyzing Neurologic Innovations
CIBC Corporate and Investment Banking (A)–1987-92
Steinway and Sons
Kent Chemicals
TSG Hoffenheim Football in the Age of Analytics
